AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Cystinosis and Mitochondrial Metabolism

RecruitingNAAges 2 Years - anyAllHospices Civils de Lyon
💬

In plain words

What the trial is, and whether it could suit you

Cystinosis is a monogenic autosomal recessive lysosomal storage disease with complete penetrance, caused by a biallelic mutation in the CTNS gene (17p13.2) encoding cystinosin, a ubiquitous membrane protein whose role is to clear cystine into the cytosol. Its dysfunction in patients with cystinosis leads to systemic accumulation of cystine, an oxidised dimer of cysteines linked by a disulphide bridge, in the lysosomal space, and irreversible cellular dysfunction. Renal damage is at the forefront, with Fanconi syndrome (proximal tubulopathy) and chronic renal failure developing early in childhood/adolescence. There are also multi-systemic disorders, notably endocrine and ophthalmological. Cysteamine is an amino thiol which reduces the level of intra-lysosomal cystine by breaking the disulphide strands of cystine, giving two cysteines which complex with cysteamine to leave the lysosome. Si

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Patient with genetically confirmed nephropathic cystinosis * Men and women, children and adults with cystinosis * Undergoing conservative treatment on native kidneys * Age ≥ 2 years * Patients receiving oral cysteamine * Patients with social security coverage * Informed consent signed by the participant or parents or legal guardians before participating in the study Exclusion Criteria: * Patient not complying with study procedures * Transplant or dialysis patient * Patient on anticalcineurin * Pregnant or breast-feeding woman * Person deprived of liberty by a judicial or administrative decision * Person not affiliated to a social security scheme or beneficiaries of a similar scheme
💊

What it tests

  • Mitochondrial metabolism
📍

Where

9 sites
Service de néphrologie pédiatrique, Hôpital Femme Mère Enfant, Hospices Civils de Lyon
Bron, France
Service de Néphrologie pédiatrique, Hôpital Jeanne de Flandre
Lille, France
Service de néphrologie et exploration fonctionnelle rénale, Hôpital Edouard Herriot, Hospices Civils de Lyon
Lyon, France
Service de Néphrologie pédiatrique, Hôpital de la Timone
Marseille, France
Service de Néphologie et endocrinologie pédiatrique, Hôpital Arnaud de Villeneuve
Montpellier, France
Service de Néphrologie pédiatrique, Hôpital Necker-Enfants Malades
Paris, France
Service de Néphrologie-transplantation rénale adultes, Hôpital Necker-Enfants Malades
Paris, France
Service de Néphrologie pédiatrique, Hôpital Robert Debré
Paris, France

…and 1 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy